| Nutraceuticals’ novel formulations: the good, the bad, the unknown and patents involved NA Helal, HA Eassa, AM Amer, MA Eltokhy, I Edafiogho, MI Nounou Recent patents on drug delivery & formulation 13 (2), 105-156, 2019 | 134 | 2019 |
| Integrated continuous manufacturing in pharmaceutical industry: current evolutionary steps toward revolutionary future NA Helal, O Elnoweam, HA Eassa, AM Amer, MA Eltokhy, MA Helal, ... Pharmaceutical patent analyst 8 (4), 139-161, 2019 | 26 | 2019 |
| Enhancement of zaleplon oral bioavailability using optimized self-nano emulsifying drug delivery systems and its effect on sleep quality among a sample of psychiatric patients. EAM Khalifa MKA, Salem HA, Shawky SM, Eassa HA Drug Deliv. 26 (1), 1243-1253, 2019 | 18 | 2019 |
| Microneedle-based vaccine delivery: Review of an emerging technology I Mansoor, HA Eassa, KHA Mohammed, MA Abd El-Fattah, MH Abdo, ... AAPS PharmSciTech 23 (4), 103, 2022 | 17 | 2022 |
| Zolmitriptan intranasal spanlastics for enhanced migraine treatment; formulation parameters optimized via quality by design approach A Saleh, M Khalifa, S Shawky, A Bani-Ali, H Eassa Scientia pharmaceutica 89 (2), 24, 2021 | 16 | 2021 |
| Effect of penetration enhancers on in vitro permeation of Nystatin from topical formulations ESHA Marzouk MA, Amal A, Darwish MK International Journal of Drug Discovery 4 (2), 153-159, 2012 | 10 | 2012 |
| Current topical strategies for skin-aging and inflammaging treatment: science versus fiction. HA Eassa, MA Eltokhy, HA Fayyaz, MKA Khalifa, S Shawky, NA Helal, ... Journal of Cosmetic Science 71 (5), 2020 | 8 | 2020 |
| Mobile-based augmented reality application in pharmacy schools implemented in pharmaceutical compounding laboratories: Students’ benefits and reception MI Nounou, HA Eassa, K Orzechowski, HA Eassa, J Edouard, N Stepak, ... Pharmacy 10 (4), 72, 2022 | 6 | 2022 |
| The safety, efficacy and pharmaceutical quality of male enhancement nutraceuticals bought online: Truth versus claim MI Nounou, HA Eassa, NA Helal, K AboulFotouh, I Mansoor, IK Latz, ... Journal of Integrative Medicine 19 (3), 232-242, 2021 | 6 | 2021 |
| Lornoxicam-loaded nanosponges for controlled anti-inflammatory effect: In vitro/in vivo assessment SM Shawky, MK Khalifa, HA Eassa Int. J. Appl. Pharm 12 (6), 217-223, 2020 | 6 | 2020 |
| Is active targeting of brain metastases of breast cancer superior to passive targeting? NMI Kamal NH, El-Amrawy F, Ali HA, Edafiogho I J Cancer Metastasis Treat 5 (11), 2019 | 5 | 2019 |
| Nanoparticles of a pyrazolo-pyridazine derivative as potential EGFR and CDK-2 inhibitors: design, structure determination, anticancer evaluation and in silico studies HE Hashem, AEGE Amr, AA Almehizia, AM Naglah, BM Kariuki, ... Molecules 28 (21), 7252, 2023 | 2 | 2023 |
| Preformulation, Development and in in Vitro Study of Bilayer Tablets of Lornoxicam AHA Marzouk MA, Ammar AA, Darwish MK Asian J. Pharm. Hea. Sci. 7 (4), 2017 | 2 | 2017 |
| Effectiveness of epigallocatechin gallate nanoparticles on the in-vivo treatment of Alzheimer’s disease in a rat/mouse model: a systematic review MKA Khalifa, SA Abdel-Sattar, OM Amin, NA Kohaf, HS Zaky, ... DARU Journal of Pharmaceutical Sciences, 1-19, 2023 | 1 | 2023 |
| Exosomes: double-edged weapon in cancer therapy HA Eassa Current Pharmaceutical Design 29 (30), 2366-2368, 2023 | 1 | 2023 |
| 3D-Printed Microfluidics Potential in Combating Future and Current Pandemics (COVID-19) HA Eassa, NA Helal, AM Amer, A Fouad, AF Bedair, R Nagib, I Mansoor, ... Recent Advances in Drug Delivery and Formulation: Formerly Recent Patents on …, 2022 | 1 | 2022 |
| Are Male Enhancement Ultraceuticals Sold Online Safe, Natural and Compliant with their Label Claim? N Amine, C Zheng, H Kaur, J Sweeney, M Mikail, HA Eassa, MI Nounou Clin Med 1 (1), 1006, 2019 | 1 | 2019 |
| One size does not fit all: Pharmacists’ perspectives on disparities in quality care provided to adult patients on the Autism Spectrum Disorder OA Ghoneim, HA Eassa, LM Lavoura, N Bianculli, C Mann Azhar International Journal of Pharmaceutical and Medical Sciences 2 (1 …, 2022 | | 2022 |
| Effect of penetration enhancers on in vitro permeation of Nystatin from topical formulations ESHA Marzouk MA, Amal A, Darwish MK International Journal of Drug Discovery 4 (2), 153-159, 2012 | | 2012 |
| Formulation and Evaluation of Topical Formulations of Nystatin ESHA Marzouk MA, Amal A, Darwish MK Egypt. J. Biomed. Sci. 37 (11), 145-159, 2011 | | 2011 |
